Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Authors
Keywords
-
Journal
BMC CANCER
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2009-12-17
DOI
10.1186/1471-2407-9-444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
- (2015) Véronique Mathieu et al. NEOPLASIA
- Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment
- (2010) M.E. Eichhorn et al. CANCER BIOLOGY & THERAPY
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
- (2009) Sonja Loges et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
- (2009) Walid S. Kamoun et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
- (2009) Elizabeth R. Gerstner et al. Nature Reviews Clinical Oncology
- Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours
- (2008) Hans Skovgaard Poulsen et al. ACTA ONCOLOGICA
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
- (2008) T. Martens et al. CLINICAL CANCER RESEARCH
- Bevacizumab in the Treatment of a Patient with Metastatic Colorectal Carcinoma with Brain Metastases
- (2008) Achala Bhaskara et al. Clinical Colorectal Cancer
- Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety
- (2008) Tyler Y. Kang et al. JOURNAL OF NEURO-ONCOLOGY
- Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
- (2008) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging
- (2008) A. Stadlbauer et al. JOURNAL OF NUCLEAR MEDICINE
- Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
- (2008) A. Claes et al. MOLECULAR CANCER THERAPEUTICS
- Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model
- (2008) Kristoph Jahnke et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- The effect of bevacizumab (Avastin) on neuroimaging of brain metastases
- (2008) Marlon S. Mathews et al. SURGICAL NEUROLOGY
- Response criteria for glioma
- (2008) A Gregory Sorensen et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now